<?xml version="1.0" encoding="UTF-8"?>
<p id="Par72">Furthermore, one could argue that RCTs and cohort studies measuring other outcomes than HIV viral suppression, HCV SVR and TB treatment completions should be included for a wider range of integrated models. On the other hand, subjective outcomes such as self-reported adherence to treatment approaches, change of substance use, and as well as self-reported change of risk behavior are substantiality uncertain outcomes, which are affected by weaknesses. These risks are potentially more pronounced among people who actively use drugs than others due to the drugs effect on cognitive functions [
 <xref ref-type="bibr" rid="CR45">45</xref>]. Due to these argumentations, in this review we want to identify all high-quality studies with hard outcomes on at least one of the infectious diseases.
</p>
